1MK Stock Chart & Stats
€0.06
>-€0.01(-5.00%)
At close: 4:00 PM EST
€0.06
>-€0.01(-5.00%)
Day’s Range― - ―
52-Week Range€0.05 - €0.21
Previous CloseN/A
Volume0.00
Average Volume (3M)1.56K
Market Cap
€30.66M
Enterprise Value€14.00
Total Cash (Recent Filing)€4.97M
Total Debt (Recent Filing)€12.08M
Price to Earnings (P/E)7.7
Beta0.48
Next Earnings
Oct 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding195,260,220
10 Day Avg. Volume0
30 Day Avg. Volume1,558
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.65
Price to Sales (P/S)1.55
P/FCF Ratio-3.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)€7.75M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsConsistently high gross margins (~75% in 2025) indicate strong unit economics across the CLE system and consumables. Durably high product margins provide a structural buffer to fund R&D, service and sales efforts, and to absorb SG&A while scaling installed base and recurring consumable sales.
Revenue Rebound / Commercial TractionA 57.5% revenue rebound to ~€8.2M in 2025 signals regained commercial traction and market acceptance of the CLE platform. Over a multi-month horizon this supports installed-base growth, recurring consumable demand and the potential to convert fixed costs into operating leverage if growth is sustained.
Material DeleveragingSignificant debt reduction (from ~€31.9M to ~€12.1M) improves solvency headroom and reduces refinancing and interest pressure. Structurally, lower leverage increases financial flexibility to invest in commercialization, negotiate supplier terms and reduces short-term solvency risk while executing growth initiatives.
Bears Say
Deep Operating LossesAn operating margin near -83% shows core operations are not generating profit and fixed cost commitments exceed current revenue. Persistently negative operating profitability is a structural risk: without sustained revenue scale or meaningful cost restructuring, losses will continue to erode resources and hinder path to self-sufficiency.
Persistent Cash BurnNegative operating cash flow and free cash flow in 2025, and across years, indicate inability to convert operations into cash. This durable cash burn forces ongoing external funding, constrains investment in sales/installation and product development, and elevates liquidity and execution risk over coming months.
Negative Shareholders' EquityA negative equity position (~-€4.8M) reflects accumulated deficits and a weak balance-sheet cushion. Structurally this limits access to non-dilutive capital, increases sensitivity to shocks, complicates lender negotiations and may necessitate dilutive financing to fund growth or cover persistent losses.
MAUNA KEA TECHNOLOGIES News
1MK FAQ
What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?
MAUNA KEA TECHNOLOGIES lowest stock price was €0.05 and its highest was €0.21 in the past 12 months.
What is MAUNA KEA TECHNOLOGIES’s market cap?
MAUNA KEA TECHNOLOGIES’s market cap is €30.66M.
When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?
MAUNA KEA TECHNOLOGIES’s upcoming earnings report date is Oct 08, 2026 which is in 64 days.
How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?
MAUNA KEA TECHNOLOGIES released its earnings results on Apr 22, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.
Is MAUNA KEA TECHNOLOGIES overvalued?
According to Wall Street analysts MAUNA KEA TECHNOLOGIES’s price is currently Overvalued.
Does MAUNA KEA TECHNOLOGIES pay dividends?
MAUNA KEA TECHNOLOGIES does not currently pay dividends.
What is MAUNA KEA TECHNOLOGIES’s EPS estimate?
MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MAUNA KEA TECHNOLOGIES have?
MAUNA KEA TECHNOLOGIES has 195,260,220 shares outstanding.
What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?
MAUNA KEA TECHNOLOGIES reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.143%.
Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?
Currently, no hedge funds are holding shares in DE:1MK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MAUNA KEA TECHNOLOGIES
Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and urology. Central to its portfolio is Cellvizio, an in vivo cellular imaging platform that delivers real-time data. This innovative system assists medical practitioners in tracking disease evolution, evaluating immediate physiological responses, delineating ambiguous tissue areas, and providing guidance during surgical procedures. Founded in 2000, the company's headquarters are situated in Paris, France.